Search
for
Sort by
Research 61–90 of 87
- Premature Graying of Hair: A Comprehensive Review and Recent Insights
- Medical Dermatology
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Alopecia areata as a complication of hair restoration surgery
- Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- Industry updates in advanced therapy medicinal products and regenerative medicine – March 2026
- Discoid Lupus and Other Lupus-Related Hair Loss
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Review of Promising Off-Label Use of Deucravacitinib
- Gray Hair: From Preventive to Treatment
- Single-Nucleus and Bulk RNA Sequencing Reveals the Involvement of Natural Killer and CD8+ T Cells in the Progression of Androgenetic Alopecia
- Repurposed Drugs: Current Trends in Drug Discovery
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Prevalence and Predictors of Premature Graying of Hair Before the Age of 30: A Cross‐Sectional Study in Saudi Arabia
- Review of Drug Repositioning in Cancer Therapeutics
- Intrinsic and Extrinsic Factors Associated with Hair Graying (Canities) and Therapeutic Potential of Plant Extracts and Phytochemicals
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- The possibilities of correction of premature greying of hair and involutive hair changes
- Hair repigmentation of poliosis circumscripta in androgenetic alopecia patient treated with exosomes and fractional picosecond laser
- Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection
- Role of Drug Repurposing in Sustainable Drug Discovery
- Lymphoma Specialists Lament the Discontinuation of Underprescribed Bexxar
- 69-Year-Old Man With Dysuria and Right Lower Abdominal Pain
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- Hair repigmentation associated with the use of lenalidomide: Graying may not be an irreversible process!
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus